Attached files
| file | filename |
|---|---|
| 10-K - Shengtai Pharmaceutical, Inc. | v197503_10k.htm |
| EX-23.1 - Shengtai Pharmaceutical, Inc. | v197503_ex23-1.htm |
| EX-31.1 - Shengtai Pharmaceutical, Inc. | v197503_ex31-1.htm |
| EX-32.2 - Shengtai Pharmaceutical, Inc. | v197503_ex32-2.htm |
| EX-31.2 - Shengtai Pharmaceutical, Inc. | v197503_ex31-2.htm |
| EX-23.2 - Shengtai Pharmaceutical, Inc. | v197503_ex23-2.htm |
EXHIBIT
32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
PURSUANT
TO SECTION 18 U.S.C SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Shengtai Pharmaceutical, Inc., the
“Company,” on Form 10-K for the fiscal year ended June 30, 2010 as filed with
the Securities and Exchange Commission on the date hereof, the “Report,” I,
Qingtai Liu , Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to my knowledge:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d), of the
Securities Exchange Act of 1934; and
2. That
the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
Date:
September 28, 2010
|
SHENGTAI
PHARMACEUTICAL, INC.
|
|
|
/s/ Qingtai Liu
|
|
|
Qingtai
Liu
|
|
|
Chief
Executive Officer
|